Dr. Anand Shah

FDA issues guidance for conducting clinical trials during COVD-19 pandemic

FDA issues guidance for conducting clinical trials during COVD-19 pandemic

WASHINGTON — The U.S. Food and Drug Administration Wednesday has issued a guidance for industry, investigators and institutional review boards conducting clinical trials during the coronavirus (COVID-19) pandemic. The FDA recognizes that the COVID-19 pandemic may impact the conduct of clinical trials of medical products, including drugs, devices and biological products. Challenges may arise, for example,